Showing 21-30 of 3101 results for "".
- MS Diagnosis: Sizing Up the Suspectshttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pn0205pg52-56-pdf/31493/Diagnosing multiple sclerosis (MS) remains one of the most challenging tasks in neurology due to its diverse clinical presentations and numerous mimicking conditions. In Jeffrey I. Greenstein’s February 2005 article in *Practical Neurology*, the complexities of differentiating MS from other neurolog
- What to Expect When the MS Patient is Expectinghttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0708MSPregFea-pdf/31007/Multiple sclerosis (MS) typically manifests in individuals during their late 20s, with an average onset age of 28 for women and early 30s for men. Relapsing-remitting MS is the most prevalent form, predominantly affecting females, while primary progressive MS shows equal incidence across genders. Re
MS Minute: Mood Disorders and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-mood-disorders-and-multiple-sclerosis/32076/Individuals with MS are at twice the risk of suicide than the general population, so it’s vital for clinicians to screen for depression and to provide various treatment options.Patients Report Delays in MS Diagnosis, High Interest in Oral Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/patients-report-delays-in-ms-diagnosis-high-interest-in-oral-therapy/30673/Nationwide survey provides a snapshot of “MS in America.”- Bad Reception: When MS Patients Are on a Different Wavelengthhttps://practicalneurology.com/columns/practice-management/bad-reception-when-ms-patients-are-on-a-different-wavelength/31064/Enhancing Physician-Patient Relationships to Improve MS Patient RetentionMaintaining strong physician-patient alliances is crucial in managing Multiple Sclerosis (MS), a chronic and unpredictable neurological disorder. According to a January 2008 article in Practical Neurology, MS patients frequentl
The Changing World of MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0209_03-php/30946/A new study has attempted to establish the global epidemiology of MS at every corner of the globe. Do your assumptions match emerging realities?- Identifying Neurobehavioral Changes in MS Patientshttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PD0806ChangesInMSfea-pdf/31278/Neurobehavioral Changes in Multiple Sclerosis: A Comprehensive OverviewMultiple sclerosis (MS) is traditionally recognized for its neuromuscular symptoms; however, recent research underscores significant neurobehavioral alterations, including cognitive impairments and neuropsychiatric disorders. Cog
MS Minute: Disparities in Multiple Sclerosis: Incorporating Equity Into Clinical Care and Research
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-disparities-in-multiple-sclerosis-incorporating-equity-into-clinical-care-and-research/32018/Assessing biologic, genetic, and social factors of patients with MS to shrink the gap in care for underrepresented populations.Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.MS Minute: Multiple Sclerosis & the Gut Microbiome
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-multiple-sclerosis-the-gut-microbiome/31927/The gut microbiome and its relationship with MS is an exciting and active area of research with much promise and much to be elucidated.